Panhematin

BIOLOGICAL2 trials

Sponsors

Rush University Medical Center, The University of Texas Medical Branch, Galveston

Conditions

Acute PorphyriasMyelodysplastic Syndrome

Phase 2

Phase 2, Open-Label, Multi-Dose Study of Panhematin in Patients With MDS

TerminatedNCT00467610

Rush University Medical CenterMyelodysplastic Syndrome

Start: 2007-05-31End: 2009-01-31Updated: 2014-10-24

Controlled Trial of Panhematin in Treatment of Acute Attacks of Porphyria

CompletedNCT02180412

The University of Texas Medical Branch, GalvestonAcute Porphyrias

Start: 2014-04-28End: 2022-02-03Updated: 2025-04-11